Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of YHP2406 and YHR2501 in Healthy Subjects
NCT06920719Phase 1Completed
- Sponsor
- Yuhan
- Start
- Jun 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of YHP2406 (2 arms), sponsored by Yuhan. Primary endpoints: Area under the plasma drug concentration-time curve from time 0 to the last measurable concentration and Maximum plasma concentration. Started Jun 2025; status: completed.
02
Drugs
YHP2406
Beyond the preview
Go deeper on NCT06920719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06920719.